DOI: 10.36347/sjds.2023.v10i12.002

Pages: 289-295

Background: Invasive mycormucosis is a rare opportunistic fungal disease with high morbidity and mortality rates, predominantly affecting immunosuppressed patients. An increasing incidence has recently been described particularly among corona virus epidemic. Dentists should be aware of this possible diagnosis instead of just instituting some useless and devastating treatments, and to ovoid the delay that can cost the patient ‘life juste like our case. Clinical presentation: An unusual clinical manifestation of mucormycosis in a 42–year-old _man, diabetic who was referred by his Otorhinolaryngologist, to our dental surgery unit of the university hospital FARHAT HACHED Tunisia, suspecting a facial cellulitis related to dental infection. Before consulting his Otorhinolaryngologist, the patient was suffering from severe dental pain for two months, without any signs of relief despite dental treatments and the pain killers prescribed by his dentist. He was successfully treated by a combination of surgical intervention and antifungal treatment: Amphotericin B. Conclusion: Invasive mycormucosis is an emerging infection and is probably related to an increase in immunosuppressed patients. Accurate oral examination may lead to early diagnosis avoiding further damages of this agressive disease.